CERIBELL INC
CBLLNASDAQπ #2355 by market capUS Equity
ββ
Quote unavailableTrack CBLL
Get earnings, price moves & breaking news on Telegram
24hβ
7dβ
14dβ
30dβ
ytdβ
1yβ
π¦Market Cap
$1.04B
Small Cap
πRevenue Growth (YoY)
36.1%
High Growth
πGross Margin
88.9%
High
π΅FCF Margin
-55.3%
Thin
βοΈP/S Ratio
10.2x
Elevated
Otter Score
64
Fair
No chart data available for CBLL.
Trading Snapshot
- Day Range
- β
- 52-Week Range
- $10.85 β $28.11
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 38.4M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $89M
- Last Q Revenue
- $28M
- P/E Ratio
- -15.5
- P/S Ratio
- 10.2x
- EPS (TTM)
- $-1.74
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +19.3%
CERIBELL INC
CBLLFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$89Mβ² +36.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
87.9%β² +1.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$58Mβ² +47.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$42Mβ² +14.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
37.2Mβ² +19.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$18MβΌ β$154M YoY
About CERIBELL INC
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)πQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
β‘Momentumβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Fair
64/100
Analyst data unavailable.
Latest News & Updates
News unavailable.